Literature DB >> 26857333

The complexity of diagnosing postural orthostatic tachycardia syndrome: influence of the diurnal variability.

Jangsup Moon1, Han Sang Lee2, Jung-Ick Byun2, Jun-Sang Sunwoo2, Jung-Won Shin3, Jung-Ah Lim2, Tae-Joon Kim2, Yong-Won Shin2, Keon-Joo Lee2, Daejong Jeon2, Keun-Hwa Jung2, Soon-Tae Lee2, Ki-Young Jung2, Kon Chu4, Sang Kun Lee5.   

Abstract

We investigated how the diagnosis of postural orthostatic tachycardia syndrome (POTS) would be changed due to diurnal variability in orthostatic tachycardia. The orthostatic vital sign test was administered to each patient twice, in the afternoon of the day of admission and the next morning (n = 113). Forty-six patients were diagnosed with POTS, and the remaining 67 patients were assigned to non-POTS group. Heart rate increments after standing were larger in the morning than in the afternoon in every group (all P < .001). Among the POTS patients, 82.6% fulfilled the diagnostic criteria for POTS in the morning and 52.2% in the afternoon. Most POTS group (65.2%) displayed normal result on single orthostatic vital sign test. Orthostatic intolerance symptoms were provoked in only 45.7% of the POTS patients, more frequently in the morning. In conclusion, diurnal variability in hemodynamic parameters and provoked symptoms significantly challenged the diagnosis of POTS.
Copyright © 2016 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Postural tachycardia syndrome; diurnal variability; orthostatic hypotension; orthostatic intolerance; orthostatic tachycardia

Mesh:

Year:  2016        PMID: 26857333     DOI: 10.1016/j.jash.2016.01.011

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  7 in total

1.  Efficacy of Propranolol, Bisoprolol, and Pyridostigmine for Postural Tachycardia Syndrome: a Randomized Clinical Trial.

Authors:  Jangsup Moon; Do-Yong Kim; Woo-Jin Lee; Han Sang Lee; Jung-Ah Lim; Tae-Joon Kim; Jin-Sun Jun; Byeongsu Park; Jung-Ick Byun; Jun-Sang Sunwoo; Soon-Tae Lee; Keun-Hwa Jung; Kyung-Il Park; Ki-Young Jung; Manho Kim; Sang Kun Lee; Kon Chu
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

2.  Diagnostic Value of Diurnal Variability of Orthostatic Heart Rate Increment in Children and Adolescents With POTS.

Authors:  Hong Cai; Shuo Wang; Runmei Zou; Fang Li; Juan Zhang; Yuwen Wang; Yi Xu; Cheng Wang
Journal:  Front Pediatr       Date:  2021-05-13       Impact factor: 3.418

3.  Orthostatic intolerance symptoms are associated with depression and diminished quality of life in patients with postural tachycardia syndrome.

Authors:  Jangsup Moon; Do-Yong Kim; Jung-Ick Byun; Jun-Sang Sunwoo; Jung-Ah Lim; Tae-Joon Kim; Jung-Won Shin; Woo-Jin Lee; Han Sang Lee; Jin-Sun Jun; Kyung-Il Park; Keun-Hwa Jung; Soon-Tae Lee; Ki-Young Jung; Kon Chu; Sang Kun Lee
Journal:  Health Qual Life Outcomes       Date:  2016-10-12       Impact factor: 3.186

Review 4.  Postural Orthostatic Tachycardia Syndrome and Its Unusual Presenting Complaints in Women: A Literature Minireview.

Authors:  Ibrar Anjum; Wafa Sohail; Betul Hatipoglu; Robert Wilson
Journal:  Cureus       Date:  2018-04-05

5.  Human leukocyte antigen associations in postural tachycardia syndrome.

Authors:  Yong-Won Shin; Jangsup Moon; Tae-Joon Kim; Do-Yong Kim; Hyeyeon Chang; Jin-Sun Jun; Soon-Tae Lee; Keun-Hwa Jung; Kyung-Il Park; Ki-Young Jung; Manho Kim; Sang Kun Lee; Kon Chu
Journal:  Ann Clin Transl Neurol       Date:  2019-04-04       Impact factor: 4.511

6.  Intracranial compliance is associated with symptoms of orthostatic intolerance in chronic fatigue syndrome.

Authors:  Andreas Finkelmeyer; Jiabao He; Laura Maclachlan; Andrew M Blamire; Julia L Newton
Journal:  PLoS One       Date:  2018-07-03       Impact factor: 3.240

7.  Heart rate and heart rate variability comparison between postural orthostatic tachycardia syndrome versus healthy participants; a systematic review and meta-analysis.

Authors:  Joel Swai; Zixuan Hu; Xiexiong Zhao; Tibera Rugambwa; Gui Ming
Journal:  BMC Cardiovasc Disord       Date:  2019-12-30       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.